Bringing best-practice neuromodulation to the GCC

neurocare is a global platform for brain-focused therapy, established in Europe since 2015, and now in the UK, the US, Australia, and the Middle East. Driven by our vision to advance global health, resilience, and performance, we empower clinicians with integrated tools, diagnostics, and education - enabling you to apply best practices and achieve outstanding results for your patients and your clinic.

Our solutions, recognized by authorities such as the FDA, NICE and MOHAP, set new standards in personalized, non-invasive, evidence-based care.

"We listened to clinicians and patients: clinical practice needs a more psychosomatic approach. We empower clinicians to deliver innovative neuromodulation at the highest standards.”

^{Thomas Mechtersheimer
Founder & CEO of neurocare group}